Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma

  1. Krystian Jazdzewski*,
  2. Elizabeth L. Murray,
  3. Kaarle Franssila,
  4. Barbara Jarzab§,
  5. Daniel R. Schoenberg, and
  6. Albert de la Chapelle*,
  1. *Human Cancer Genetics Program, Comprehensive Cancer Center, Ohio State University, 850 Biomedical Research Tower, 460 West 12th Avenue, Columbus, OH 43210;
  2. Department of Molecular and Cellular Biochemistry, Ohio State University, 366 Hamilton Hall, 1645 Neil Avenue, Columbus, OH 43210;
  3. Department of Pathology, Helsinki University Central Hospital, FIN-00029, Helsinki, Finland; and
  4. §Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Wybrzeze Armii Krajowej 15, Gliwice 44-101, Poland
  1. Contributed by Albert de la Chapelle, March 17, 2008 (received for review February 12, 2008)

Abstract

Although papillary thyroid carcinoma (PTC) displays strong heritability, no predisposing germ-line mutations have been found. We show that a common G/C polymorphism (rs2910164) within the pre-miR-146a sequence reduced the amount of pre- and mature miR-146a from the C allele 1.9- and 1.8-fold, respectively, compared with the G allele. This is matched by a similar decrease in the amount of each pre-miR generated from the corresponding pri-miR-146a in an in vitro processing reaction. The C allele also interfered with the binding of a nuclear factor to pre-miR-146a. The reduction in miR-146a led to less efficient inhibition of target genes involved in the Toll-like receptor and cytokine signaling pathway (TRAF6, IRAK1), and PTC1 (also known as CCDC6 or H4), a gene frequently rearranged with RET proto-oncogene in PTC. In an association study of 608 PTC patients and 901 controls, we found marked differences in genotype distribution of rs2910164 (P = 0.000002), the GC heterozygous state being associated with an increased risk of acquiring PTC (odds ratio = 1.62, P = 0.000007), and both homozygous states protective with odds ratio = 0.42 for the CC genotype (P = 0.003) and odds ratio = 0.69 for the GG genotype (P = 0.0006). Moreover, 4.7% of tumors had undergone somatic mutations of the SNP sequence. Thus, our data suggest that a common polymorphism in pre-miR-146a affects the miR expression, contributes to the genetic predisposition to PTC, and plays a role in the tumorigenesis through somatic mutation. Preliminary evidence suggests that these effects are mediated through target genes whose expression is affected by the SNP status.

Footnotes

  • To whom correspondence should be addressed. E-mail: albert.delachapelle{at}osumc.edu
  • Author contributions: K.J., D.R.S., and A.d.l.C. designed research; K.J. and E.L.M. performed research; K.J., K.F., and B.J. contributed new reagents/analytic tools; K.J., E.L.M., D.R.S., and A.d.l.C. analyzed data; and K.J., D.R.S., and A.d.l.C. wrote the paper.

  • The authors declare no conflict of interest.

  • This article contains supporting information online at www.pnas.org/cgi/content/full/0802682105/DCSupplemental.

« Previous | Next Article »Table of Contents